The Dutchman
01 Mar 2017
Re: RNS:new major shareholder do you know exactly who they are - they are investing a lot in small British Co's
valuemanbuyer
01 Mar 2017
Re: RNS:new major shareholder They are a private office - nothing to do with state funds.
The Dutchman
01 Mar 2017
Re: RNS:new major shareholder Interesting devolopment. I recognise the name as they also own a stake in PRV (Porvair) which is my second largest shareholding ( Ideagen is well down my list). On that bulletin board we also couldnt find anything about Lind LV. My guess is that they are linked to the Norwegian state investment fund - which is HUGE in comparison with the size of the country. Compare how the Brits invested their N Sea Oil money - but that's a discussion for another day.I think you will find that Lind were already a shareholder but this purchase crossed the threshold for disclosure. I hope we find that Lind is a long term player, they appear to be over in PRV where they bought when we all thought the price was high and yet the share price went up another 25% over the following 6 months and they continue to hold. Sovereign wealth funds are by there nature long term investors.
gretel
01 Mar 2017
RNS:new major shareholder Interesting RNS today - Vind LV have become major shareholders, buying another 3m shares and now holding 8.3m, or 4.55%. They're Norwegian and that's about all I can find:[link]
Willow67
21 Feb 2017
Sold 1/3 Sold out of around 1/3 of my holding today at 80p. Happy for it to go either way from here although my gut is we will see mid 70's again at some time. Will sell another 1/3 if we reach 85p in this run.
Willow67
20 Feb 2017
Re: More new highs now Yep, impressive rise again today. The shares are now at my predicted level to close 2017, so I am probably too pessimistic. I guess the market is discounting the 24 PER the shares will be trading at when we reach the April y/e a couple of months out from now (those results are pretty predictable now) and looking ahead to y/e 2018 where EPS of 3.9 puts them on a PER approaching 20, which would feel a sensible multiple given the ballpark 20% EPS growth we have been seeing in recent years. It will be really interesting to see whether Hornsby goes for another big acquisition or continues with these small bolt-ons. Gael in Dec 2014 led to a 30% dilution as none of us were allowed to participate in the associated rights issue, but it obviously worked out well because he bought it for x8 their then current year EBITDA. I cant see a scenario where he over-pays or over-reaches. The probable worst case scenario is that their isn't much corporate activity and the shares become a bit dull.
gretel
20 Feb 2017
More new highs now and ticking up again today despite two 200k trades at 76.5p.IDEA will soon be moving into a year with forecasts of 3.9p EPS, so with more earnings-enhancing acquisitions likely given the sound Balance Sheet the P/E still looks reasonable to me.
Willow67
15 Feb 2017
Re: Shares Its my biggest holding of any share so long may it continue. I AM wondering how possible it will be for them to win larger contracts over the next phase of their growth; £100k contracts are great but will only get them so far. I don't have a strong sense of whether those are out there to be won or not.
Prezza
15 Feb 2017
Re: Shares Take the point on toppy PER Willow but the results justify the upgrade and it feels like a company which is moving from a teen to an adult profile . I would like to see some volume though, a great investment.. Regards Prezza
Willow67
14 Feb 2017
Shares Fantastic performance from the shares, even if volume is low. Pushing well north of 20 PER now so to me starting to look a rich here. From any technical perspective I am aware of the shares look high also. Makes me wonder if something is happening we aren't aware of ...
gretel
02 Feb 2017
Excellent NHS contract win News - this sounds significant in reputational terms and as a great reference point for further such wins:[link] NHS Foundation Trust work with Ideagen to improve patient experience and safety across Kent health economy02 February 2017Ideagen to provide the Trust with electronic order communications system in six-figure project Medway NHS Foundation Trust, which serves a community of approximately 400,000 and 70 GP practices, is working with software firm Ideagen to introduce an electronic order communications system. The Kent-based NHS Foundation Trust will adopt Ideagen OCM, Ideagen’s order communications system, in a six-figure project. Focusing initially on pathology and radiology investigations, Ideagen OCM will be launched across the whole health economy, including external GP practices, prisons and other local care providers. The system will be expanded to other diagnostic services such as cardiorespiratory over time. Chris Stiff, IT Programme Manager for the Trust who is overseeing the roll out of the new system, said: “This exciting new software solution will enhance both patient care and experience.“At the moment, everything is manual and paper-based in regards to order communications and therefore, with the high number of requests processes, the opportunity for data entry errors is very high.“The Ideagen OCM project will allow us to significantly reduce our data entry error rate and allow for almost all requests to be made and received electronically.“Electronic ordering of investigations will enable immediate cross-checking with previous requests to ensure the appropriateness of these requests and avoid duplication or unnecessary investigations.“Although we will still receive some paper requests from those in the field, such as community midwives and district nurses, Ideagen OCM will significantly reduce those requests. As a result, this will improve overall data quality and reduce the costs associated with processing each paper request.“This will enhance not just the experience and day-to-day working practices for staff, but also the experience for patients and increase and above all else, patient safety.”Ideagen OCM is a browser-based order communications system which has been developed to meet the needs of pathology, radiology and other diagnostics services in both primary care and hospital departments. It is currently used extensively across the UK’s NHS, with millions of requests processed by thousands of clinicians every year. As well as enhancing the experience for both staff and patients, the Medway Ideagen OCM project will also help the Trust as it works to meet the Government’s ‘Paperless 2020’ target, which is aimed at digitising the NHS. Mr Stiff added: “This project certainly ties in with the paperless 2020 manifesto and we are looking forward to working with a single system, which will provide increased visibility and communications across primary and secondary care in Kent and Medway.”Kevin McSharry, Ideagen’s Head of Healthcare, said: “We are absolutely delighted and extremely excited to be working with Medway NHS Foundation Trust on this project – which is a forward thinking project in line with the UK Government’s paperless NHS demands. "Our Ideagen OCM software is very much at the forefront in the quest to modernise order communications within healthcare and we are looking forward to this project with Medway immensely."
gretel
01 Feb 2017
RNS : Investec increase above 14% Investec have increased to above 14% with 25.6m shares:[link] FYI, at yesterday's Cenkos Growth Company Show, Richard Penny (senior fund manager at L&G UK Alpha Trust) noted IDEA as one of his "Investable UK tech opportunities under the Big Data category in his presentation.
gretel
24 Jan 2017
Re: Interims Yep, a rather buoyant set of interim results today:[link] revenues are up nicely:"Recurring revenues represent 56% (2015: 53%) of overall revenues and are equivalent to 90% (2015: 87%) of fixed operating costs"More acquisitions look likely:"All three acquisitions enhance the Group's business platform. The Board continues to pursue acquisition opportunities in line with its stated strategy of acquiring complementary businesses that have strong IP and significant recurring revenues."And lots of confidence going forward:"David Hornsby, CEO of Ideagen, commented: "We are delighted to report on another strong performance from the Group across all of our vertical markets during the first half of the year. As well as recording significant organic growth and a further increase in revenues, the Group has successfully acquired and integrated two companies in the period which marks a return to our strategy of acquiring businesses with strong IP and recurring revenues. In addition, we have achieved strong momentum within our SaaS based business which has helped increase recurring revenues and supports the Group's medium term strategy to transition from a predominantly perpetual to a predominantly SaaS based licence model. Current trading is robust and remains in line with both market and management expectations. As such, long term prospects for the Group remain positive and we are confident in the outlook for the rest of the year." "
Willow67
24 Jan 2017
Interims Another great set of results with organic growth and cash in line with the trading update given earlier. 2nd half of the year will see Covalent and IPI add their contributions to EBITDA of about £0.5m which together with some organic growth means a 15%+ rise in full year profits feels already in the bag. Cash generation is now up to an annualised £6m+ from £4.9m a year ago. Strong momentum confirmed across their businesses. I'm not sure any of this suggests an immediate significant increase in the shares given it all feels well-flagged but it certainly justifies the recent rise and suggests to me the Finncap target for this year of 78p is probably about the right sort of expectation to have. 100p in 2018?
gretel
13 Jan 2017
Re: Finncap top tip for 2017 [link] "Ideagen named in finnCap ‘TopTen’ for 2017 12 January 2017 Ideagen has been named in the top ten small cap share tips for 2017 by finnCap, the leading independent broker and advisor for companies operating on the AIM market and London Stock Exchange. Ideagen was commended thanks to its “strong record of coupling organic growth with strategic acquisitions” and “consistently delivering on forecasts”.The company’s performance helped its market value surge from £11 million in 2012 to today’s value of over £110 million. A finnCap spokesman, quoted in an article on the Interactive Investor website, said: “There is now another certainty in life in addition to death and taxes – compliance.“With momentum behind the Ideagen software group, earnings are expected to jump by over 20% this year, which could underpin a leap in its share price to 78p – 16% higher than current levels.“Ideagen’s market value has already surged from £11 million in 2012 to over £110 million, which should attract bigger investors.”As well as significant organic growth in the last few years, Ideagen has made a number of strategic and significant acquisitions to boost its product suite, staff numbers and revenues. In just nine years, the software firm has made a total of 11 acquisitions. In 2016 alone, the company acquired UK-based Covalent Software Ltd and IPI Solutions Ltd while Bulgaria’s Logen Ltd was also added to the wider Group.“Even in tough economic circumstances,” says Raymond Greaves, finnCap’s head of research. “Companies with good ideas, innovative technology, clever business models and strong management can generate their own luck and continue to thrive.”"
